Roth Capital Comments on Celsius' Q2 Earnings (NASDAQ:CELH)

Key Points

• Roth Capital has upgraded their earnings per share (EPS) estimates for Celsius Holdings for Q2 2026, now forecasting $0.46, which is an increase from their previous estimate of $0.45.
• Celsius reported a net margin of 7.91% and quarterly revenue of $739.30 million, surpassing analysts' expectations, with an 83.9% year-over-year revenue increase.
• Several analysts continue to issue positive ratings for Celsius, with target prices ranging from $64.00 to $75.00, reflecting strong confidence in the company's performance.

Celsius Holdings Inc. (NASDAQ:CELH - Free Report) - Equities research analysts at Roth Capital lifted their Q2 2026 earnings per share (EPS) estimates for Celsius in a report released on Tuesday, September 2nd. Roth Capital analyst S. Mcgowan now forecasts that the company will earn $0.46 per share for the quarter, up from their prior forecast of $0.45. Roth Capital has a "Buy" rating and a $70.00 price target on the stock. The consensus estimate for Celsius' current full-year earnings is $0.89 per share. Roth Capital also issued estimates for Celsius' Q3 2026 earnings at $0.39 EPS, Q4 2026 earnings at $0.36 EPS, FY2026 earnings at $1.42 EPS and FY2027 earnings at $1.95 EPS.

Celsius (NASDAQ:CELH - Get Free Report) last released its earnings results on Thursday, August 7th. The company reported $0.47 EPS for the quarter, beating analysts' consensus estimates of $0.23 by $0.24. Celsius had a return on equity of 36.88% and a net margin of 7.91%.The business had revenue of $739.30 million for the quarter, compared to analysts' expectations of $632.13 million. During the same quarter in the prior year, the firm earned $0.28 earnings per share. The firm's revenue was up 83.9% on a year-over-year basis.

A number of other research analysts have also recently issued reports on the company. Wall Street Zen cut Celsius from a "buy" rating to a "hold" rating in a research note on Sunday, August 17th. JPMorgan Chase & Co. raised their price objective on Celsius from $44.00 to $54.00 and gave the company an "overweight" rating in a research note on Thursday, July 31st. Truist Financial raised their price objective on Celsius from $55.00 to $65.00 and gave the company a "buy" rating in a research note on Monday, August 11th. Cowen reaffirmed a "buy" rating on shares of Celsius in a research note on Tuesday. Finally, Bank of America raised their price objective on Celsius from $35.00 to $40.00 and gave the company an "underperform" rating in a research note on Friday, August 8th. Seventeen investment analysts have rated the stock with a Buy rating, three have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $59.89.

Celsius Trading Down 3.9%

Shares of NASDAQ:CELH traded down $2.39 on Wednesday, reaching $58.37. 5,976,793 shares of the company traded hands, compared to its average volume of 6,431,793. The business's 50-day simple moving average is $51.32 and its 200 day simple moving average is $41.13. Celsius has a 52 week low of $21.10 and a 52 week high of $63.50. The stock has a market capitalization of $15.06 billion, a P/E ratio of 157.76, a price-to-earnings-growth ratio of 1.32 and a beta of 1.34. The company has a current ratio of 2.11, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68.

Institutional Trading of Celsius

Institutional investors and hedge funds have recently bought and sold shares of the stock. Hantz Financial Services Inc. lifted its holdings in Celsius by 1,476.0% in the second quarter. Hantz Financial Services Inc. now owns 788 shares of the company's stock worth $37,000 after buying an additional 738 shares during the period. Westside Investment Management Inc. purchased a new stake in Celsius in the first quarter worth about $32,000. Summit Securities Group LLC purchased a new stake in Celsius in the first quarter worth about $34,000. MassMutual Private Wealth & Trust FSB lifted its holdings in Celsius by 255.1% in the first quarter. MassMutual Private Wealth & Trust FSB now owns 1,044 shares of the company's stock worth $37,000 after buying an additional 750 shares during the period. Finally, EverSource Wealth Advisors LLC lifted its holdings in Celsius by 244.3% in the second quarter. EverSource Wealth Advisors LLC now owns 1,119 shares of the company's stock worth $52,000 after buying an additional 794 shares during the period. 60.95% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Celsius

In other news, major shareholder Deborah Desantis sold 100,000 shares of the stock in a transaction dated Thursday, July 31st. The shares were sold at an average price of $47.50, for a total transaction of $4,750,000.00. Following the completion of the sale, the insider directly owned 17,717,770 shares in the company, valued at approximately $841,594,075. This represents a 0.56% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Jarrod Langhans sold 5,000 shares of the stock in a transaction dated Monday, August 18th. The stock was sold at an average price of $60.00, for a total transaction of $300,000.00. Following the sale, the chief financial officer owned 104,227 shares of the company's stock, valued at approximately $6,253,620. This represents a 4.58% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 1,123,641 shares of company stock valued at $52,998,580 in the last quarter. 2.55% of the stock is currently owned by company insiders.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.